Transmission, Human Population, and Pathogenicity: the Ebola Case in Point

Microbiol Spectr. 2018 Mar;6(2). doi: 10.1128/microbiolspec.MTBP-0003-2016.

Abstract

The 2013-2016 Ebola outbreak in West Africa has been the largest ever of a known disease in a new context that produced an unprecedented impact and is changing the international approach to responding to public health emergencies. The unprecedented scale of the outbreak, the use of advanced technology for detecting and characterizing the infectious agent, along with the opportunity to treat patients in modern facilities have greatly increased our knowledge of the disease and its transmission. Also, for the first time, an important international effort has been deployed to control the spread of the epidemic by providing care to patients and by adopting basic measures of public health control. Apart from supportive treatment and intensive therapy with fluids and electrolytes, no new compounds have been proved to be clinically effective to treat Ebola virus disease; however, a specific vaccine has shown significant protection in clinical trials in Guinea, opening an expectation for controlling future outbreaks.

Keywords: Ebola virus; Ebola virus disease; R0; filovirus; hemorrhagic fever; reproductive number; transmission; vaccines.

Publication types

  • Historical Article
  • Review

MeSH terms

  • Africa, Western / epidemiology
  • Delivery of Health Care
  • Disease Outbreaks / history
  • Disease Outbreaks / prevention & control
  • Disease Transmission, Infectious / prevention & control
  • Ebolavirus / genetics
  • Ebolavirus / pathogenicity
  • Emergencies
  • Epidemics / prevention & control
  • Hemorrhagic Fever, Ebola / epidemiology*
  • Hemorrhagic Fever, Ebola / prevention & control
  • Hemorrhagic Fever, Ebola / therapy
  • Hemorrhagic Fever, Ebola / transmission*
  • History, 21st Century
  • Humans
  • Public Health*
  • Virulence